Cedric Ghevaert MD, PhD, FRCP, FRCPath

Cédric Ghevaert graduated from the medical school of the University Libre de Bruxelles in 1997 and subsequently became a fellow of the Royal College of Physicians, London (2000). He specialised in Haematology and became a fellow of the Royal College of Pathologists in 2005. He obtained his PhD in 2008 studying novel antibodies for the treatment of bleeding in neonates in Cambridge. He obtained a personal Intermediate Clinical Fellowship from the British Heart Foundation whilst working in Prof Steve Watson's group at the university of Birmingham in 2009. He took up the post of Senior Lecturer in Transfusion Medicine at the University of Cambridge in 2010, a post funded by the NHS Blood and Transplant and in 2020 was promoted to Reader in Transfusion Medicine. In addition to his academic post, Professor Ghevaert also works as a Consultant Haematologist for the NHSBT. The main focus of Dr. Ghevaert group’s research is the production of blood cells for human use, namely red cells and platelets. They have developed a particular expertise in the production of these cell types from human pluripotent stem cells using methodologies that are compatible with the production of clinical grade products within the constraints of affordable manufacturing processes. To this end they are combining cellular programming through knowledge and manipulation of transcription factor networks and the creation of 3D biocompatible niches and bioreactors.　 Cedric has expertise recognised world-wide in carrying out first-in-man studies of pluripotent stem cell derived blood cell survival and recovery in human volunteers. He is the clinical lead for 3 such trials due to take place in the next 5 years on the Cambridge Biomedical Campus.